Veramyst and Nucynta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veramyst (fluticasone furoate) and Nucynta (tapentadol hydrochloride). Common drug interactions include pneumonia among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Veramyst and Nucynta. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Veramyst?

Veramyst has active ingredients of fluticasone furoate. It is often used in allergies. eHealthMe is studying from 3,444 Veramyst users. Check the latest studies of Veramyst.

What is Nucynta?

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. eHealthMe is studying from 31,818 Nucynta users. Check the latest studies of Nucynta.

On Jul, 18, 2026

19 people who take Veramyst and Nucynta together, and have interactions are studied.

What are the common drug interactions of Veramyst and Nucynta, by gender? *:

female:

Pneumonia
Pulmonary mass
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Emotional distress
Fear
Injury
Pulmonary embolism (blockage of the main artery of the lung)

male:

Depression
Hospitalisation
Hypersensitivity
Insomnia (sleeplessness)
Lung disorder (lung disease)
Oral discomfort (pain or irritation in mouth)
Somnolence (a state of near-sleep, a strong desire for sleep)
Therapeutic response unexpected
Weight increased
Schizophrenia (a mental disorder characterized by a breakdown of thought processes)

What are the common drug interactions of Veramyst and Nucynta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Diarrhoea
Insomnia (sleeplessness)

30-39:

Ankle fracture
Confusional state
Encephalopathy (functioning of the brain is affected by some agent or condition)
Gout (uric acid crystals building up in the body)
Lung disorder (lung disease)
Somnolence (a state of near-sleep, a strong desire for sleep)
Therapeutic response unexpected

40-49:

Quality of life decreased
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Emotional distress
Fear
Injury
Pulmonary embolism (blockage of the main artery of the lung)

50-59:

n/a

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 73.68%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 57.89%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
Multiple Myeloma (cancer of the plasma cells): 2 people, 10.53%
Vitamin D Decreased: 1 person, 5.26%
Dry Mouth: 1 person, 5.26%
Hypersensitivity: 1 person, 5.26%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 5.26%
Gastric Ph Decreased: 1 person, 5.26%
Fungal Infection: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Veramyst and Nucynta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously